Method for predicting susceptibility to radiation pneumonitis

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/28 (2006.01) C12Q 1/26 (2006.01) G01N 33/573 (2006.01)

Patent

CA 2653977

Provided is a method for determining whether an individual is likely to be susceptible to radiation pneumonitis from radiation therapy and for developing a treatment based on the determination of susceptibility. The method involves measuring SOD and GPX activity levels. A high SOD or low GPX activity, or a combination thereof, is indicative that the individual is likely to be susceptible to radiation pneumonitis.

La présente invention concerne un procédé permettant de déterminer si un individu court le risque de développer une sensibilité à une pneumonite à la suite de radiations thérapeutiques et de mettre au point un traitement basé sur la détermination de la sensibilité. Le procédé implique une mesure des niveaux d'activité SOD et GPX. Une forte activité SOD ou une faible activité GPX, ou une combinaison des deux, est indicative du risque que court l'individu de développer une sensibilité à une pneumonite résultant d'une irradiation.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method for predicting susceptibility to radiation pneumonitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for predicting susceptibility to radiation pneumonitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for predicting susceptibility to radiation pneumonitis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1645459

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.